BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 10354138)

  • 1. Clinical significance of cyclin-dependent kinase inhibitor p27Kip1 expression and proliferation in non-Hodgkin's lymphoma: independent prognostic value of p27Kip1.
    Moller MB; Skjodt K; Mortensen LS; Pedersen NT
    Br J Haematol; 1999 Jun; 105(3):730-6. PubMed ID: 10354138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor.
    Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M
    Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.
    Kudoh S; Kumaravel TS; Kuramavel B; Eguchi M; Asaoku H; Dohy H; Fujiwara M; Sasaki N; Tanaka K; Kamada N
    Jpn J Cancer Res; 1999 Nov; 90(11):1262-9. PubMed ID: 10622539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cyclin-dependent kinase inhibitor p27kip1 in malignant lymphomas.
    Oh YH; Park CK
    J Korean Med Sci; 2000 Aug; 15(4):399-406. PubMed ID: 10983687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index.
    Sánchez-Beato M; Sáez AI; Martínez-Montero JC; Sol Mateo M; Sánchez-Verde L; Villuendas R; Troncone G; Piris MA
    Am J Pathol; 1997 Jul; 151(1):151-60. PubMed ID: 9212741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclin D3 expression in non-Hodgkin lymphoma. Correlation with other cell cycle regulators and clinical features.
    Møller MB; Nielsen O; Pedersen NT
    Am J Clin Pathol; 2001 Mar; 115(3):404-12. PubMed ID: 11242797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of p27Kip1 and Ki-67 expression in carcinoma of the renal pelvis and ureter.
    Kamai T; Takagi K; Asami H; Ito Y; Arai K; Yoshida KI
    BJU Int; 2000 Jul; 86(1):14-9. PubMed ID: 10886076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulators p27 and pRb in lymphomas - correlation with histology and proliferative activity.
    Kiviniemi M; Sauroja I; Rajamäki A; Punnonen K; Söderström KO; Salminen E
    Br J Cancer; 2000 Nov; 83(9):1161-7. PubMed ID: 11027429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of p27Kip1 and cyclin D1 proteins is inversely correlated and is associated with poor clinical outcome in human gastric cancer.
    Han S; Kim HY; Park K; Lee MS; Kim HJ; Kim YD
    J Surg Oncol; 1999 Jul; 71(3):147-54. PubMed ID: 10404130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p27KIP1 is abnormally expressed in Diffuse Large B-cell Lymphomas and is associated with an adverse clinical outcome.
    Sáez A; Sánchez E; Sánchez-Beato M; Cruz MA; Chacón I; Muñoz E; Camacho FI; Martínez-Montero JC; Mollejo M; García JF; Piris MA
    Br J Cancer; 1999 Jul; 80(9):1427-34. PubMed ID: 10424746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth regulation by p27Kip1 is abrogated by multiple mechanisms in aggressive malignant lymphomas.
    Lin Z; Lim S; Lim MS
    Br J Haematol; 2003 Jun; 121(5):739-48. PubMed ID: 12780788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: inverse correlation with disease-free survival.
    Flørenes VA; Maelandsmo GM; Kerbel RS; Slingerland JM; Nesland JM; Holm R
    Am J Pathol; 1998 Jul; 153(1):305-12. PubMed ID: 9665492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-phase kinase-associated protein 2 expression in non-Hodgkin's lymphoma inversely correlates with p27 expression and defines cells in S phase.
    Chiarle R; Fan Y; Piva R; Boggino H; Skolnik J; Novero D; Palestro G; De Wolf-Peeters C; Chilosi M; Pagano M; Inghirami G
    Am J Pathol; 2002 Apr; 160(4):1457-66. PubMed ID: 11943729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin-dependent kinase inhibitor p27Kip1 expression and interaction with other cell cycle-associated proteins in mammary carcinoma.
    Gillett CE; Smith P; Peters G; Lu X; Barnes DM
    J Pathol; 1999 Jan; 187(2):200-6. PubMed ID: 10365095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent expression of cyclin-dependent kinase inhibitors (CKI) and p14ARF/p16 beta in non-Hodgkin's lymphomas and chronic lymphocytic leukemia.
    Pabst T; Peters UR; Tinguely M; Schwaller J; Tschan M; Aebi S; Vonlanthen S; Borisch B; Betticher DC; Zimmermann A; Tobler A; Fey MF
    Leuk Lymphoma; 2000 May; 37(5-6):639-48. PubMed ID: 11042528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients.
    Korkolopoulou P; Vassilopoulos I; Konstantinidou AE; Zorzos H; Patsouris E; Agapitos E; Davaris P
    Gynecol Oncol; 2002 Jun; 85(3):404-14. PubMed ID: 12051866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic impact of cyclin-dependent kinase inhibitor p27kip1 in node-positive breast cancer.
    Tsuchiya A; Zhang GJ; Kanno M
    J Surg Oncol; 1999 Apr; 70(4):230-4. PubMed ID: 10219018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of p27KIP1 protein and ki-67 growth fraction in non-small cell lung cancers.
    Hommura F; Dosaka-Akita H; Mishina T; Nishi M; Kojima T; Hiroumi H; Ogura S; Shimizu M; Katoh H; Kawakami Y
    Clin Cancer Res; 2000 Oct; 6(10):4073-81. PubMed ID: 11051259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cell cycle regulator p27Kip1 is correlated with survival of patients with astrocytoma.
    Mizumatsu S; Tamiya T; Ono Y; Abe T; Matsumoto K; Furuta T; Ohmoto T
    Clin Cancer Res; 1999 Mar; 5(3):551-7. PubMed ID: 10100706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.